RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and ChinaAs Chinese pharmaceutical companies engaged in more international transactions with undervalued deals, China's primary intent in this undervaluing is to gain a better understanding of market dynamics and the general valuation of their assets during deal-making discussions, so that they can ultimately cease better control over the global deal-making process at the expense of US biopharmaceutical industry.